社区

It's pricey today, but it has what it takes for a long run of strong growth.

FinTech stocks Square,PayPal and Coinbase all rose more than 3% in Monday morning trading.

Shares of Wells Fargo & Co. $(WFC)$ advanced 1.31% to $47.02 Friday, on what proved to be an all-aro

Electric vehicle company intends to sell trucks and SUVs to consumers, delivery vans to Amazon. Rivian Automotive Inc., which is working on electric delivery vans for Amazon.com Inc. in addition to electric trucks for consumers, filed for an initial public offering Friday.Rivian launched the R1T, an electric pickup truck meant for consumers, in September. The company said in its filing with the Securities and Exchange Commission that it intends to launch and deliver the R1S, a sport-utility vehi

临近周末，咱们来聊聊有关操作的两三事。 多年以前，我曾想过一个问题，散户有机会打败机构吗？或许现在来看，你可以举出近期轰动金融圈的Gamestop事件，可在当年那个时代，没人认为有机会，可又发现其实高手在民间，就算数量不多，还是能人辈出的。 深入观察那些在操作的路上有所成就的人之后，发现了一个有趣的现象。正所谓戏法人人会变，各有巧妙不同，每个在操作上有卓越绩效的人，多半有自己过人的能力，可能是基本面、也或许是技术面。也许对企业财报、宏观数据了如指掌，又或者是对产业变化、政策走向有敏锐的嗅觉。大家都有其独到的长处，所以才能胜出。掌握的资源不同，胜出的模式就不一样，但中间都会有一个共通点，那就是打破信息不对称。 股市有句谚语：「股价总是涨在题材、盘在营收、跌在盈馀」，也有另一个说法是「买谣言、卖事实」，讲的都是同一件事：操作领先的重要性。对一个自然投资人来说（也就是散户），资金少、专业缺、信息落后，前两项不容易克服，天生处于不利，但若能改变第三项，就有一举扭转劣势的机会、反败为胜。换句话说，不管你做哪个市场、哪种策略，如何打破信息不对称的劣势，是散户进入赢者圈最关键的条件，「知所先后，则近道矣」，古人早有明训。而技术分析，就是最好的利器。 从简单的逻辑来看，技术分析之所以具有判断多空的参考价值，就是在于市场信息优越者虽不会透露其所知，但他们却会在交易上留下轨迹。通过有效解读市场的交易信息，就能「侧写」出信息优越者的多空意图，进一步掌握多空变化。当年，我就是因为这个「侧写」说法，将本科所学的财务理论搁置，一头栽入技术分析的领域。时至今日，倍感收获良多。 学理上，根据诺贝尔奖得主Fama的有效市场假说，就算是弱式有效市场，任何交易信息都无法获取超额利润，更不用说是半强式有效市场及强式有效市场。因此，技术分析不具有操作参考意义。可实务上，我们却可见到有效的技术分析可以在操作上取得很好

$Pfizer(PFE)$Pfizer Covid vaccine brought in US7. 8 billion in sales alone. It has received a full FDA approval on 23 August 21 for people ages 16 and up. Now it is also getting approval for Booster shots in September and for children age 2 to 5. New tests have indicated that the vaccine is 84% effective against Covid at 6 months and highly protective against hospitalisation and death.With all these latest happenings Pfizer is on its path to stellar earnings and exponential growth ahead. This Is the best time to buy $Pfizer(PFE)$ on market weakness!